These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment. Spalletta G; Girardi P; Caltagirone C; Orfei MD J Alzheimers Dis; 2012; 29(4):761-72. PubMed ID: 22349686 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study. van Vliet D; de Vugt ME; Aalten P; Bakker C; Pijnenburg YA; Vernooij-Dassen MJ; Koopmans RT; Verhey FR Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452 [TBL] [Abstract][Full Text] [Related]
4. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Richard E; Schmand B; Eikelenboom P; Yang SC; Ligthart SA; Moll van Charante EP; van Gool WA; Dement Geriatr Cogn Disord; 2012; 33(2-3):204-9. PubMed ID: 22722671 [TBL] [Abstract][Full Text] [Related]
5. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey. Yener GG; Cogn Behav Neurol; 2009 Dec; 22(4):264-9. PubMed ID: 19996880 [TBL] [Abstract][Full Text] [Related]
6. Microglial activation occurs late during preclinical Alzheimer's disease. Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428 [TBL] [Abstract][Full Text] [Related]
7. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes. Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890 [TBL] [Abstract][Full Text] [Related]
9. Differences between the behavioral and psychological symptoms of Alzheimer's disease and Parkinson's disease. Tokuchi R; Hishikawa N; Sato K; Hatanaka N; Fukui Y; Takemoto M; Ohta Y; Yamashita T; Abe K J Neurol Sci; 2016 Oct; 369():278-282. PubMed ID: 27653908 [TBL] [Abstract][Full Text] [Related]
10. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Holthoff VA; Beuthien-Baumann B; Kalbe E; Lüdecke S; Lenz O; Zündorf G; Spirling S; Schierz K; Winiecki P; Sorbi S; Herholz K Biol Psychiatry; 2005 Feb; 57(4):412-21. PubMed ID: 15705358 [TBL] [Abstract][Full Text] [Related]
11. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment]. Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532 [TBL] [Abstract][Full Text] [Related]
12. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits. Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246 [TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Teng E; Lu PH; Cummings JL Dement Geriatr Cogn Disord; 2007; 24(4):253-9. PubMed ID: 17700021 [TBL] [Abstract][Full Text] [Related]
14. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease. Mak E; Chin R; Ng LT; Yeo D; Hameed S Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519 [TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. Palmer K; Di Iulio F; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Spalletta G J Alzheimers Dis; 2010; 20(1):175-83. PubMed ID: 20164594 [TBL] [Abstract][Full Text] [Related]
16. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. Craig D; Mirakhur A; Hart DJ; McIlroy SP; Passmore AP Am J Geriatr Psychiatry; 2005 Jun; 13(6):460-8. PubMed ID: 15956265 [TBL] [Abstract][Full Text] [Related]
17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
18. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease. Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477 [TBL] [Abstract][Full Text] [Related]
19. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease. Ribeiro DE; Petiz LL; Glaser T; Oliveira-Giacomelli Á; Andrejew R; Saab FAR; Milanis MDS; Campos HC; Sampaio VFA; La Banca S; Longo BM; Lameu C; Tang Y; Resende RR; Ferreira ST; Ulrich H Neuropharmacology; 2023 Mar; 226():109371. PubMed ID: 36502867 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease. Landes AM; Sperry SD; Strauss ME J Neuropsychiatry Clin Neurosci; 2005; 17(3):342-9. PubMed ID: 16179656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]